Our Goal
We are a global pharmaceutical company, determined to make healthcare affordable as well as effective and high quality through excellence in research,manufacturing and marketing.
Our business focus is patient-centric and is continuously evolving to bring innovative speciality products to the global healthcare market.
We are committed to providing innovative and sustainable solutions in healthcare and create long-term value for society, our stakeholders and the scientific community.
Our Focused Therapeutic Segments are:
Anti Infectives
(Injectables)
Anti Cancer
(Injectables & Orals)
Contrast Media
(Injectables)
Critical and General
Care (Injectables)
Operations
| Business Overview | |
|---|---|
| Focus market | EU, CIS, LATAM, Middle East, Brazil, Canada, Australia, New Zealand, South Africa and West Africa. |
| Focus therapies | Anti-infectives, Oncology, Contrast Media, Critical Care |
| Countries present | 25+ |
| Product registrations | 350+ |
| Product filings | 200+ |
| Growth plans | Entry into regulated markets |
